Main
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
Register:
|
JPRN |
Last refreshed on:
|
17 October 2023 |
Main ID: |
JPRN-UMIN000001825 |
Date of registration:
|
31/03/2009 |
Prospective Registration:
|
Yes |
Primary sponsor: |
|
Public title:
|
Treatment of familial amyloid polyneuropathy (FAP) using diflunisal
|
Scientific title:
|
Treatment of familial amyloid polyneuropathy (FAP) using diflunisal - Treatment of FAP using diflunisal |
Date of first enrolment:
|
2009/04/01 |
Target sample size:
|
30 |
Recruitment status: |
Complete: follow-up complete |
URL:
|
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000002202 |
Study type:
|
Interventional |
Study design:
|
Single arm Non-randomized
|
Phase:
|
Not selected
|
|
Countries of recruitment
|
Japan
| | | | | | | |
Contacts
|
Name:
|
Shuichi Ikeda |
Address:
|
3-1-1 Asahi, Matsumoto
Japan |
Telephone:
|
|
Email:
|
|
Affiliation:
|
Shinshu University department of Medicine |
|
Name:
|
|
Address:
|
Japan |
Telephone:
|
|
Email:
|
sekijima@shinshu-u.ac.jp |
Affiliation:
|
Shinshu University department of Medicine |
| |
Key inclusion & exclusion criteria
|
Inclusion criteria:
Exclusion criteria: renal dysfunction pregnancy lactation
Age minimum:
20years-old
Age maximum:
Not applicable
Gender:
Male and Female
|
Health Condition(s) or Problem(s) studied
|
familial amyloid polyneuropathy (FAP)
|
Intervention(s)
|
Orally administration of diflunisal
|
Primary Outcome(s)
|
Clnical FAP scale compound muscle action potential
|
Secondary Outcome(s)
|
cardiac function mBMI
|
Source(s) of Monetary Support
|
Grant-in-aid for Scientific Research
|
Ethics review
|
Status: YES
Approval date:
Contact:
|
Results
|
Results available:
|
Yes |
Date Posted:
|
|
Date Completed:
|
01/03/2014 |
URL:
|
|
|
|